Transaction · 0001193125-26-398204

Bizily Scott

Bizily Scott, CLO, reported a transaction classified as exercise at 4D Molecular Therapeutics, Inc. involving 1635.000000 shares for an estimated $6768.90. Reported holdings after the transaction were 10252.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MCLO
FDMT4D Molecular Therapeutics, Inc.
Trade date
Sep 16, 2026
Filing date
Sep 22, 2026
View on SEC Insider profile
Estimated value$6.76kShares × reported price
Shares traded1.63k$4.14 per share
Holdings after10.2kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 6 calendar days after the transaction date.

FDMT price since this filing

Daily closing prices, with the filing date and available return windows
FDMT · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -8.4%1w ago -10.7%1d ago -14.2%
Returns since7d -8.8%30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001193125-26-398204
Common Stock
Transaction date
Sep 16, 2026
Filed Sep 22, 2026, 10:43 PM · 6d delay
Shares
1,635 sh
$4.14 per share
Estimated value
$6.76k
Computed from shares × price
Holdings after
10,252 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Delayed Filing Direct Ownership 10b5-1 Detected
Filing-only score

-10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
  • delayed_filing-6 points

    reporting_delay_days = 6

    Filing delay exceeds the configured threshold.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Legal Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on January 13, 2026.

  2. F2

    The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 6, 2025 (the "Vesting Commencement Date"), suc…

Original filing · 0001193125-26-398204
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

FDMT